In contrast to typical findings in AD patients, several studies described increased FDG uptake in transgenic AD mice including the 5XFAD, Tg2576, APPS1-21, and APP/PS1 models (27, 32, 35, 36). This evidence concerns the gene APP and Alzheimer disease.